Emily Fairbairn - Oct 4, 2024 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
INAB
Transactions as of
Oct 4, 2024
Transactions value $
$0
Form type
4
Date filed
10/8/2024, 04:15 PM
Previous filing
Jun 14, 2024
Next filing
Oct 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Series C Warrants (right to buy) Purchase +3.04M 3.04M Oct 4, 2024 Common Stock 3.04M $0.27 See Footnote F1, F2, F3
transaction INAB Pre-Funded Warrants (right to buy) Purchase +3.04M 3.04M Oct 4, 2024 Common Stock 3.04M $0.00 See Footnote F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.
F2 The reported securities are included within 3,038,743 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share Pre-funded warrant and one Series C warrant each representing the right to purchase 3,038,743 shares of common stock.
F3 The securities are held by the Malcolm and Emily Charitable Remainder Unitrust 2010 (the "Trust"). The Reporting Person is the trustee of the Trust.
F4 The Pre-funded warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.